Rocco Capuano
Salerno, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Asymptomatic spinal cord lesions in Multiple Sclerosis: A systematic review and meta-analysis of subclinical disease activity.
Journal: Multiple sclerosis and related disorders
Published: May 28, 2026
Exploring the relationship between retinal damage and cognition in multiple sclerosis: a cross-sectional OCT-MRI study.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: June 19, 2025
Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study.
Journal: Journal of neurology
Published: May 23, 2025
Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: September 22, 2023
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 11, 2023
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: February 16, 2023
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey.
Journal: Multiple sclerosis and related disorders
Published: November 16, 2022
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents.
Journal: Journal of the neurological sciences
Published: September 06, 2022
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod.
Journal: Journal of neurology
Published: June 07, 2022
Impact of post-contrast MRI in the definition of active multiple sclerosis.
Journal: Journal of the neurological sciences
Published: March 31, 2022
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod.
Journal: Multiple sclerosis and related disorders
Published: January 13, 2022
Last Updated: 09/26/2026